Preskočiť na hlavný obsah

Cookies on Centre for classification system DRG web pages

We use essential cookies to make this site work.

We also use analytics cookies, by accepting you agree to their use.

Cookie settingsAccept analytics cookiesReject analytics cookies
SlovenčinaEnglish
Login

STAY INFORMED! - If you are interested in receiving newsletters and updates, please send us your email to cksdrg@health.gov.sk

DRG search engine
News
762

Pripočítateľná položka pre rekombinantný F VII

Read more

Organisation: Fakultná nemocnica F.D.Roosevelta, Banská Bystrica

Created at: 26.03.2025

Processed at: 07.04.2026

Area

Attributable item

Subarea

Incentive to create

Question

Recombinant factor VIIa is a drug used to save life in patients with acquired hemophilia, congenital hemophilia with inhibitor, and for life-threatening bleeding, currently there has been a modification and previously requested creation of procedures 8r200.1 - 8r200.6, but there are not yet creditable items to reflect the cost of the listed drug for those procedures.

Answer

After review of ATC groups and specific drugs, the 8r300 performance was adjusted to include the requested drug Recombinant Activated Factor VII [rFVIIa], m.i.d..